Skip to search formSkip to main contentSkip to account menu

GSK961081

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Over the last decade, there has been a steady increase in the use of fixed dose combinations for the treatment of a range of… 
Highly Cited
2013
Highly Cited
2013
GSK961081 is a bifunctional molecule demonstrating both muscarinic antagonist and &bgr;-agonist activities. This was a 4-week… 
2013
2013
The aim of this study was to characterise population pharmacokinetics (PK) and pharmacodynamics (PD) of GSK961081 (MABA), a bi… 
2012
2012
Introduction GSK961081 is a dual pharmacophore demonstrating both muscarinic antagonist and beta agonist activities in one… 
2011
2011
Introduction: GSK961081 is a dual pharmacophore with both muscarinic antagonist and beta 2 agonist (MABA) activity. Objective: To…